The DOI matches its Crossref record; 142 of the 154 references it cites were found in a registry or an index; 58 of the 116 sources its claims cite were checked for support.
Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies
Open accessAbstract
An update of the chapter on Mental, Behavioral and Neurodevelopmental Disorders in the International Classification of Diseases and Related Health Problems (ICD) is of great interest around the world. The recent approval of the 11th Revision of the ICD (ICD-11) by the World Health Organization (WHO) raises broad questions about the status of nosology of mental disorders as a whole as well as more focused questions regarding changes to the diagnostic guidelines for specific conditions and the implications of these changes for practice and research. This Forum brings together a broad range of experts to reflect on key changes and controversies in the ICD-11 classification of mental disorders. Taken together, there is consensus that the WHO's focus on global applicability and clinical utility in developing the diagnostic guidelines for this chapter will maximize the likelihood that it will be adopted by mental health professionals and administrators. This focus is also expected to enhance the application of the guidelines in non-specialist settings and their usefulness for scaling up evidence-based interventions. The new mental disorders classification in ICD-11 and its accompanying diagnostic guidelines therefore represent an important, albeit iterative, advance for the field.
Overview
CoChat Summary
TL;DR
This Forum article argues that the ICD-11 mental, behavioral, and neurodevelopmental disorders chapter is an important iterative advance because it emphasizes global applicability, clinical utility, and field-tested diagnostic guidelines. It reviews major changes across disorder groups and notes that, while controversies remain, the ICD-11 should improve diagnosis, research, and care in many settings.
Key findings
- The authors state there is consensus that WHO’s focus on global applicability and clinical utility will maximize adoption by mental health professionals and administrators, improve use in non-specialist settings, and support scaling up evidence-based interventions.
- The ICD-11 simplifies and revises several diagnoses, including PTSD with 3 core symptoms; complex PTSD with added disturbances in affect regulation, self-beliefs, and relationships; and prolonged grief disorder, which can be diagnosed after 6 months (or longer where culturally normative).
- For depression, ICD-11 requires at least 5 of 10 symptoms for at least 2 weeks, with one symptom being depressed mood or diminished interest/pleasure; the paper notes the ICD-11 guideline had substantial inter-clinician reliability and very good clinical utility in field trials.
- For bipolar disorder, ICD-11 lowers the threshold for bipolar I to one or more manic or mixed episodes, requires mania to last at least 1 week unless treatment is present, and allows bipolar II as a diagnosis with equal status to bipolar I.
- The paper reports improved diagnostic reliability for psychotic disorders in ICD-11 versus ICD-10, and notes that internet-based and clinical field trials showed markedly improved reliabilities for most categories in that section.
Methods
- This is a Forum/article of expert commentaries, not an original empirical study; the editors asked authors with expertise in specific disorder areas to review ICD-11 revisions and controversies.
- The paper draws on WHO field testing, published evidence, and comparisons with DSM-5 and ICD-10 across disorder groupings such as psychotic, mood, anxiety, stress-related, feeding/eating, addictive, sexual, gender identity-related, and neurodevelopmental disorders.
- Main analysis is narrative and comparative: it synthesizes how ICD-11 diagnostic guidelines changed, how they align with evidence and DSM-5, and what the implications are for clinical practice and research.
Limitations
- The paper states that the ways in which ICD-11, DSM-5, and Research Domain Criteria have and have not advanced the field need to be further understood.
- It also notes unresolved causality and thresholding issues, and that mental disorder classification remains tentative rather than definitive.
- Evident from the text: this is a perspective/commentary article, so its conclusions are based on synthesis and expert opinion rather than a single new dataset or original statistical analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

















Verification
Claims the paper makes
47 Valid · 11 Not valid · 29 Not checked · 41 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There remains controversy around the inclusion of irritability, which is a far more non-specific phenomenon with much overlap with disorders such as ADHD, conduct disorder, and personality disorders [38].”
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Bipolar disorders > Michael Berk (Fig. 5) and Eduard Vieta (Fig. 6)
What the sources say
- Partly supportedcites [38] Berk L, Hallam KT, Venugopal K, et al. Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder. Bipolar Disord. 2017;19(3):184–97. sourceExperimental — accuracy not yet measured
The Introduction describes irritability as transdiagnostic and non-specific. The Comorbidity section says personality disorders may involve irritability and discusses conduct problems, but it does not establish overlap with ADHD or specifically describe controversy over irritability’s inclusion. Page numbers are unavailable in our copy. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“factor analytic models generally find that panic disorder clusters with phobic disorders into the fear subdomain of internalizing disorders [56]”
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Anxiety disorders and obsessive–compulsive disorder > Ymkje Anna de Vries (Fig. 8), Annelieke M. Roest (Fig. 9), Peter de Jonge (Fig. 10)
What the sources say
- Supportedcites [56] Krueger RF, Kotov R, Watson D, et al. Progress in achieving quantitative classification of psychopathology. World Psychiatry. 2018;17:282–93. source
The hierarchical-structure section places fear within the broader internalizing domain. In the evidence-for-organizational-rubrics section, Figure 3 lists panic disorder alongside social phobia, agoraphobia, and specific phobia under that hierarchy, supporting the claimed clustering. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“They are characterized by a chronic course [53, 54]”
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Anxiety disorders and obsessive–compulsive disorder > Ymkje Anna de Vries (Fig. 8), Annelieke M. Roest (Fig. 9), Peter de Jonge (Fig. 10)
What the sources say
- Supportedcites [53] Penninx BW, Nolen WA, Lamers F, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands study of depression and anxiety (NESDA). J Affect Disord. 2011;133:76–85. source
The Introduction describes anxiety disorders as often having a chronic-intermittent course. The Discussion reports that, in the study’s two-year follow-up, the anxiety group had a more chronic course than the depression group, with 41.9% experiencing chronic symptoms. (LLM, conf=0.94)
- Supportedcites [54] Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162:1179–87. source
The Conclusions describe the anxiety disorders studied as having a chronic clinical course. The Discussion qualifies this finding: it applies to the disorders examined except panic disorder without agoraphobia. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Again, mixed episodes and their treatment implications are increasingly recognized in the clinical literature [37] and this is a welcome change suggesting the need for a differentially tailored treatment approach.”
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Bipolar disorders > Michael Berk (Fig. 5) and Eduard Vieta (Fig. 6)
What the sources say
- Supportedcites [37] Malhi GS, Berk M, Morris G, et al. Mixed mood: the not so United States? Bipolar Disord. 2017;19(4):242–5. source
The Abstract discusses mixed presentations as a common clinical challenge and describes their treatment and research implications. The Author Manuscript addresses the DSM-5 mixed-features specifier and argues that more precise definitions could guide differential management, supporting the broad claim that these issues are receiving clinical attention. No page numbers are available in our copy. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As internet-based and clinical field trials have demonstrated for psychotic disorders, diagnostic reliabilities for the ICD-11 compared to the ICD-10 have markedly improved for most of the diagnostic categories in this section [31].”
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Schizophrenia or other primary psychotic disorders > Wolfgang Gaebel (Fig. 4)
What the sources say
- Partly supportedcites [31] Reed GM, Sharan P, Rebello TJ, et al. The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders: results among adult patients in mental health settings of 13 countries. World Psychiatry. 2018;17:174–86. sourceExperimental — accuracy not yet measured
The Discussion reports generally higher ICD-11 diagnostic reliability than previously reported for ICD-10, including improved reliability for schizoaffective disorder. But this paper reports a clinical field study, not an internet-based trial; it also says acute and transient psychotic disorder appeared less reliable under ICD-11 and cautions that methodological differences preclude strict comparisons. Thus it does not establish a marked improvement across most psychotic-disorder categories as stated. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
38 more claims · 17 with their cited sources checked
Create a free account to see all 128 claims and to verify the 3 references still open.
- It may state two separate claims as one. 50
- Probably not a substantial claim. 58
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most significant difference between the DSM-5 and ICD11 conceptualizations of anxiety and related disorders is in the diagnostic requirements for PTSD 15 .”
From The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management (2021) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Introduction > Dan J. Stein (Fig. 1) and Geoffrey M. Reed (Fig. 2)
“Compulsive sexual behaviour disorder”
§ Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies > Compulsive sexual behaviour disorder > Peer Briken (Fig. 16)
“although such subjective difficulty alone is not sufficient for a diagnosis of CSDB.”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
The Lancet Commission on global mental health and sustainable development
Patel, V., Saxena, S., Lund, C., Thornicroft, G., Baingana, F., Bolton, P., Chisholm, D., Collins, P. Y., Cooper, J. L., Eaton, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31612-x · Cited by 3,692
Self-citationInternational Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Injustice at Every Turn: A Report of the National Transgender Discrimination Survey
Grant, J. M., Motter, L. A., & Tanis, J. (2011) · Cited by 2,065
International Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Gómez, J. G., & Dally, P. (1979) · Cited by 1,965
Cited by
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Self-citationStein, D. J., Craske, M. G., Rothbaum, B. O., Chamberlain, S. R., Fineberg, N. A., Choi, K. W., de Jonge, P., Baldwin, D. S., & Maj, M. (2021) · World Psychiatry · doi:10.1002/wps.20919 · Cited by 60
Self-citationControversies and clinical recommendations for the treatment of compulsive sexual behavior disorder
Griffin, K. R., Way, B. M., & Kraus, S. W. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00393-5 · Cited by 43
“Given the lack of robust research methodology employed in many studies examining the clinical correlates of CSBD [4], there is the possibility of CSBD introducing the risk of misuse or misconstrual within sex-negative groups who may interpret sexual behavior as disordered even when diagnostic criteria are not met [30].”
Forrest, L. N., Jacobucci, R. C., & Grilo, C. M. (2022) · Psychological Medicine · doi:10.1017/s0033291720002287 · Cited by 21
Self-citationFrom Biomarkers to Behavior: Mapping the Neuroimmune Web of Pain, Mood, and Memory
Tanaka, M., & Battaglia, S. (2025) · Biomedicines · doi:10.3390/biomedicines13092226 · Cited by 13
“Clinically, patient-centered algorithms and interdisciplinary guidelines emerge, accelerating therapeutics from bench to bedside [81,82,84].”
Metadata
- Authors
- Stein, D. J., Szatmari, P., Gaebel, W., Berk, M., Vieta, E., Maj, M., de Vries, Y. A., Roest, A. M., de Jonge, P., Maercker, A., Brewin, C. R., Pike, K. M., Grilo, C. M., Fineberg, N. A., Briken, P., Cohen-Kettenis, P. T., & Reed, G. M.
- Affiliations
- South African Medical Research Council (ZA)
- Barwon Health (AU)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Groningen (NL)
- University College London (GB)
- Columbia University (US)
- Yale University (US)
- University of Hertfordshire (GB)
- University Medical Center Hamburg-Eppendorf (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Stein, Dan J.
- Reed, Geoffrey M.
- ORCID
- Venue
- BMC Medicine
- Published
- 2020-01-27
- Volume
- 18
- Issue
- 1
- Pages
- 21-21
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC6983973
- OpenAlex
- W3003406382
- Cited by
- 264
- References
- 137
- Citations by year
- 2026: 17 · 2025: 35 · 2024: 51 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 22
- FWCI
- 219.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Open University of Cape Town (University of Cape Town) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Pfizer
- Sanofi
- World Health Organization
- Sunovion
- Royal College of Psychiatrists
- Ministerio de Ciencia, Innovación y Universidades (PI15/00283)
- Centres de Recerca de Catalunya
- National Institute for Health and Care Research
- University of Oxford
- Beyond Blue
- South African Medical Research Council
- Generalitat de Catalunya (2017 SGR 1365, SLT006/17/00357, PERIS 2016–2020, 2017-SGR)
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- Dainippon Sumitomo Pharma
- Centro de Investigación Biomédica en Red de Salud Mental (SLT006/17/00357, 2017 SGR 1365)
- European College of Neuropsychopharmacology
- Servier
- H. Lundbeck A/S
- National Institutes of Health (UL1TR001863)
- Allergan
- Medical Research Council
- National Health and Medical Research Council (1059660 and 1156072, 1156072, 1059660)
- Instituto de Salud Carlos III (PI15/00283)
- European Regional Development Fund (2016-2020)
- National Center for Advancing Translational Sciences
- Topics
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- ICD-11, mental illness, disease classification, diagnostic classification, diagnostic guidelines, World Health Organization, global applicability, clinical utility
- MeSH terms
- Mental Disorders, Humans, International Classification of Diseases, Neurodevelopmental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies. https://app.cochat.ai/papers/10.1186/s12916-020-1495-2
- The paper
- Stein, D. J., Szatmari, P., Gaebel, W., Berk, M., Vieta, E., Maj, M., de Vries, Y. A., Roest, A. M., de Jonge, P., Maercker, A., Brewin, C. R., Pike, K. M., Grilo, C. M., Fineberg, N. A., Briken, P., Cohen-Kettenis, P. T., & Reed, G. M. (2020). Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies. BMC Medicine. https://doi.org/10.1186/s12916-020-1495-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.